NYPOZI
Google image searchProduct monograph
Active ingredient
filgrastim, 300 MCG/0.5 ML
DIN: 02520990
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS
Description: PREFILLED SYRINGE
Schedule: Prescription / Schedule D
Company: TANVEX BIOPHARMA USA, INC.
Date: 24-JAN-2024
ATC:
- L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
- L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
- L03AA — Colony stimulating factors (ATC, ATC/DDD)
- L03AA02 — FILGRASTIM (ATC/DDD)
Reference brand drug: Neupogen
